Match!
Jorge Ortiz
University of Toledo
SurgeryTransplantationDiabetes mellitusGeneral surgeryMedicine
13Publications
4H-index
58Citations
What is this?
Publications 14
Newest
#1Jerred Pletcher (UT: University of Toledo)
#2Naoru Koizumi (GMU: George Mason University)H-Index: 8
Last. Jorge Ortiz (UT: University of Toledo)H-Index: 4
view all 5 authors...
Source
#1Helen Zhang (UT: University of Toledo)H-Index: 1
#2Weikai Qu (UT: University of Toledo)H-Index: 3
Last. Jorge Ortiz (UT: University of Toledo)H-Index: 4
view all 4 authors...
Abstract Objective To determine if history of kidney transplant is an independent risk factor for increased incidence of wound infection and other morbidities in burn patients. Background While the goal of immunosuppression post-organ transplantation is to prevent graft rejection, it is often associated with significant adverse effects such as increased susceptibility to infection, drug toxicity, and malignancy. Burn injuries lead to a dysregulated hypermetabolic state and a compromised cutaneou...
Source
#1Katie Korneffel (UT: University of Toledo)
#2Graham Mitro (UT: University of Toledo)
Last. Jorge Ortiz (UT: University of Toledo)H-Index: 4
view all 5 authors...
Abstract Objectives Alemtuzumab (Ale) is a recombinant monoclonal antibody which binds to CD52 causing profound lymphodepletion, thus allowing its use in renal transplantation induction therapy. However, patients may be at increased risk for opportunistic infections, such as Cytomegalovirus (CMV). We analyzed CMV infection in renal allograft recipients administered low-dose valganciclovir (VGCV) prophylaxis with alemtuzumab induction and steroid minimization. Materials and methods In this retros...
Source
#1Joseph T. Brooks (UT: University of Toledo)H-Index: 1
#2Jorge Ortiz (UT: University of Toledo)H-Index: 4
Source
#1Paulo N.A. MartinsH-Index: 19
#2Margaux N. Mustian (UAB: University of Alabama at Birmingham)H-Index: 4
Last. Jayme E. Locke (UAB: University of Alabama at Birmingham)H-Index: 26
view all 15 authors...
7 CitationsSource
#1Joseph T. Brooks (UT: University of Toledo)H-Index: 1
#2Naoru Koizumi (GMU: George Mason University)H-Index: 8
Last. Jorge Ortiz (George Washington University Hospital)H-Index: 4
view all 8 authors...
Abstract Background Share 35 prioritizes offers of deceased donor livers to regional candidates with Model for End-Stage Liver Disease (MELD) ≥35 over local candidates with lower MELD scores. Analysis of Share35 has shown that overall 1- or 2-year post-transplant (LTx) outcomes have been unchanged while waitlist mortality has been reduced. However, these studies exclude retransplant (reLTx) recipients. This study aims to investigate the outcomes of liver retransplants in evaluating the impact of...
Source
Source
#1Graham Mitro (UT: University of Toledo)
#2Weikai Qu (UT: University of Toledo)H-Index: 3
Last. Jorge Ortiz (UT: University of Toledo)H-Index: 4
view all 9 authors...
Source
Source
Source
12